Global Gastrointestinal OTC Drugs Market Size, Share, Trends and Forecast 2021-2027

Description

The global Gastrointestinal OTC Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
Global Gastrointestinal OTC Drugs Scope and Segment
Gastrointestinal OTC Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal OTC Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.
The following manufacturers are covered in this report:
GlaxoSmithKline
Pfizer
Johnson & Johnson
Bayer
Procter & Gamble
Perrigo
Abbott
Sanofi
Teva Pharmaceutical
Nestle
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma
Gastrointestinal OTC Drugs Breakdown Data by Type
Laxatives
Anti-Flatulents
H2-Antaginists
Anti-Diarrheals
PPIs
Anti-Emetics
Other
Gastrointestinal OTC Drugs Breakdown Data by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional and Country-level Analysis
The Gastrointestinal OTC Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Gastrointestinal OTC Drugs market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2016-2027. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2016-2027.
Competitive Landscape and Gastrointestinal OTC Drugs Market Share Analysis

TABLE OF CONTENT

1 Study Coverage
1.1 Gastrointestinal OTC Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Gastrointestinal OTC Drugs Market Size Growth Rate by Type
1.4.2 Laxatives
1.4.3 Anti-Flatulents
1.2.4 H2-Antaginists
1.2.5 Anti-Diarrheals
1.2.6 PPIs
1.2.7 Anti-Emetics
1.2.8 Other
1.3 Market by Application
1.3.1 Global Gastrointestinal OTC Drugs Market Size Growth Rate by Application
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Gastrointestinal OTC Drugs Sales Estimates and Forecasts 2016-2027
2.2 Global Gastrointestinal OTC Drugs Revenue Estimates and Forecasts 2016-2027
2.3 Global Gastrointestinal OTC Drugs Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Gastrointestinal OTC Drugs Regions by Sales
2.4.1 Global Top Gastrointestinal OTC Drugs Regions by Sales (2016-2021)
2.4.2 Global Top Gastrointestinal OTC Drugs Regions by Sales (2022-2027)
2.5 Global Top Gastrointestinal OTC Drugs Regions by Revenue
2.5.1 Global Top Gastrointestinal OTC Drugs Regions by Revenue (2016-2021)
2.5.2 Global Top Gastrointestinal OTC Drugs Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Gastrointestinal OTC Drugs Sales by Manufacturers
3.1.1 Global Top Gastrointestinal OTC Drugs Manufacturers by Sales (2016-2021)
3.1.2 Global Top Gastrointestinal OTC Drugs Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Gastrointestinal OTC Drugs Sales in 2020
3.2 Global Gastrointestinal OTC Drugs Revenue by Manufacturers
3.2.1 Global Top Gastrointestinal OTC Drugs Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Gastrointestinal OTC Drugs Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Gastrointestinal OTC Drugs Revenue in 2020
3.3 Global Gastrointestinal OTC Drugs Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Gastrointestinal OTC Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Gastrointestinal OTC Drugs Sales by Type
4.1.1 Global Gastrointestinal OTC Drugs Historical Sales by Type (2016-2021)
4.1.2 Global Gastrointestinal OTC Drugs Forecasted Sales by Type (2022-2027)
4.1.3 Global Gastrointestinal OTC Drugs Sales Market Share by Type (2016-2027)
4.2 Global Gastrointestinal OTC Drugs Revenue by Type
4.2.1 Global Gastrointestinal OTC Drugs Historical Revenue by Type (2016-2021)
4.2.2 Global Gastrointestinal OTC Drugs Forecasted Revenue by Type (2022-2027)
4.2.3 Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2016-2027)
4.3 Global Gastrointestinal OTC Drugs Price by Type
4.3.1 Global Gastrointestinal OTC Drugs Price by Type (2016-2021)
4.3.2 Global Gastrointestinal OTC Drugs Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Gastrointestinal OTC Drugs Sales by Application
5.1.1 Global Gastrointestinal OTC Drugs Historical Sales by Application (2016-2021)
5.1.2 Global Gastrointestinal OTC Drugs Forecasted Sales by Application (2022-2027)
5.1.3 Global Gastrointestinal OTC Drugs Sales Market Share by Application (2016-2027)
5.2 Global Gastrointestinal OTC Drugs Revenue by Application
5.2.1 Global Gastrointestinal OTC Drugs Historical Revenue by Application (2016-2021)
5.2.2 Global Gastrointestinal OTC Drugs Forecasted Revenue by Application (2022-2027)
5.2.3 Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2016-2027)
5.3 Global Gastrointestinal OTC Drugs Price by Application
5.3.1 Global Gastrointestinal OTC Drugs Price by Application (2016-2021)
5.3.2 Global Gastrointestinal OTC Drugs Price Forecast by Application (2022-2027)

6 North America
6.1 North America Gastrointestinal OTC Drugs Market Size by Type
6.1.1 North America Gastrointestinal OTC Drugs Sales by Type (2016-2027)
6.1.2 North America Gastrointestinal OTC Drugs Revenue by Type (2016-2027)
6.2 North America Gastrointestinal OTC Drugs Market Size by Application
6.2.1 North America Gastrointestinal OTC Drugs Sales by Application (2016-2027)
6.2.2 North America Gastrointestinal OTC Drugs Revenue by Application (2016-2027)
6.3 North America Gastrointestinal OTC Drugs Market Size by Country
6.3.1 North America Gastrointestinal OTC Drugs Sales by Country (2016-2027)
6.3.2 North America Gastrointestinal OTC Drugs Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Gastrointestinal OTC Drugs Market Size by Type
7.1.1 Europe Gastrointestinal OTC Drugs Sales by Type (2017-2027)
7.1.2 Europe Gastrointestinal OTC Drugs Revenue by Type (2017-2027)
7.2 Europe Gastrointestinal OTC Drugs Market Size by Application
7.2.1 Europe Gastrointestinal OTC Drugs Sales by Application (2017-2027)
7.2.2 Europe Gastrointestinal OTC Drugs Revenue by Application (2017-2027)
7.3 Europe Gastrointestinal OTC Drugs Market Size by Country
7.3.1 Europe Gastrointestinal OTC Drugs Sales by Country (2017-2027)
7.3.2 Europe Gastrointestinal OTC Drugs Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Gastrointestinal OTC Drugs Market Size by Type
8.1.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Type (2018-2027)
8.1.2 Asia Pacific Gastrointestinal OTC Drugs Revenue by Type (2018-2027)
8.2 Asia Pacific Gastrointestinal OTC Drugs Market Size by Application
8.2.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Application (2018-2027)
8.2.2 Asia Pacific Gastrointestinal OTC Drugs Revenue by Application (2018-2027)
8.3 Asia Pacific Gastrointestinal OTC Drugs Market Size by Region
8.3.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2018-2027)
8.3.2 Asia Pacific Gastrointestinal OTC Drugs Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Gastrointestinal OTC Drugs Market Size by Type
9.1.1 Latin America Gastrointestinal OTC Drugs Sales by Type (2019-2027)
9.1.2 Latin America Gastrointestinal OTC Drugs Revenue by Type (2019-2027)
9.2 Latin America Gastrointestinal OTC Drugs Market Size by Application
9.2.1 Latin America Gastrointestinal OTC Drugs Sales by Application (2019-2027)
9.2.2 Latin America Gastrointestinal OTC Drugs Revenue by Application (2019-2027)
9.3 Latin America Gastrointestinal OTC Drugs Market Size by Country
9.3.1 Latin America Gastrointestinal OTC Drugs Sales by Country (2019-2027)
9.3.2 Latin America Gastrointestinal OTC Drugs Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Gastrointestinal OTC Drugs Market Size by Type
6.1.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Type (2016-2027)
6.1.2 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Type (2016-2027)
6.2 Middle East and Africa Gastrointestinal OTC Drugs Market Size by Application
6.2.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Application (2016-2027)
6.2.2 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Application (2016-2027)
6.3 Middle East and Africa Gastrointestinal OTC Drugs Market Size by Country
6.3.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2016-2027)
6.3.2 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E

11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Product Description
11.1.5 GlaxoSmithKline Related Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Pfizer Gastrointestinal OTC Drugs Product Description
11.2.5 Pfizer Related Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Overview
11.3.3 Johnson & Johnson Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Johnson & Johnson Gastrointestinal OTC Drugs Product Description
11.3.5 Johnson & Johnson Related Developments
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Overview
11.4.3 Bayer Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Bayer Gastrointestinal OTC Drugs Product Description
11.4.5 Bayer Related Developments
11.5 Procter & Gamble
11.5.1 Procter & Gamble Corporation Information
11.5.2 Procter & Gamble Overview
11.5.3 Procter & Gamble Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Procter & Gamble Gastrointestinal OTC Drugs Product Description
11.5.5 Procter & Gamble Related Developments
11.6 Perrigo
11.6.1 Perrigo Corporation Information
11.6.2 Perrigo Overview
11.6.3 Perrigo Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Perrigo Gastrointestinal OTC Drugs Product Description
11.6.5 Perrigo Related Developments
11.7 Abbott
11.7.1 Abbott Corporation Information
11.7.2 Abbott Overview
11.7.3 Abbott Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Abbott Gastrointestinal OTC Drugs Product Description
11.7.5 Abbott Related Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Overview
11.8.3 Sanofi Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Sanofi Gastrointestinal OTC Drugs Product Description
11.8.5 Sanofi Related Developments
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Corporation Information
11.9.2 Teva Pharmaceutical Overview
11.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Product Description
11.9.5 Teva Pharmaceutical Related Developments
11.10 Nestle
11.10.1 Nestle Corporation Information
11.10.2 Nestle Overview
11.10.3 Nestle Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Nestle Gastrointestinal OTC Drugs Product Description
11.10.5 Nestle Related Developments
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Product Description
11.1.5 GlaxoSmithKline Related Developments
11.12 Reckitt Benckiser
11.12.1 Reckitt Benckiser Corporation Information
11.12.2 Reckitt Benckiser Overview
11.12.3 Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Reckitt Benckiser Product Description
11.12.5 Reckitt Benckiser Related Developments
11.13 Purdue Pharma
11.13.1 Purdue Pharma Corporation Information
11.13.2 Purdue Pharma Overview
11.13.3 Purdue Pharma Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Purdue Pharma Product Description
11.13.5 Purdue Pharma Related Developments

12 Value Chain and Sales Channels Analysis
12.1 Gastrointestinal OTC Drugs Value Chain Analysis
12.2 Gastrointestinal OTC Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gastrointestinal OTC Drugs Production Mode & Process
12.4 Gastrointestinal OTC Drugs Sales and Marketing
12.4.1 Gastrointestinal OTC Drugs Sales Channels
12.4.2 Gastrointestinal OTC Drugs Distributors
12.5 Gastrointestinal OTC Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Gastrointestinal OTC Drugs Industry Trends
13.2 Gastrointestinal OTC Drugs Market Drivers
13.3 Gastrointestinal OTC Drugs Market Challenges
13.4 Gastrointestinal OTC Drugs Market Restraints

14 Key Findings in The Global Gastrointestinal OTC Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample